The European Medicines Agency recently released a concept paper on the development of a guideline on quality and equivalence of topical products for public consultation. EIPG has reviewed the document and, following feedback from its members, has submitted its comments to the EMA.
-
-
News from EIPG
- Insights to the Industrial Pharmacist role for the future
- EMA’s reflection paper on AI in the pharmaceutical lifecycle
- The New Pharmaceutical Legislation
- EIPG General Assembly and Elections 2023
- EMA’s reflection paper on single-arm clinical trials
- EMA’s 3-year work plan for the Quality domain
- The debate on the “Do No Significant Harm” principle in R&D
